Next level investing into the high-tech future:

Size: px

Start display at page:

Download "Next level investing into the high-tech future:"

Bethany Peters
7 years ago
Views:

1 eithealth.eu Hyatt Regency Düsseldorf 5 th BIO.NRW Business Angel Congress Next level investing into the high-tech future: financing biotech and life sciences March, 1 st 2016, Hyatt Regency Speditionsstraße 19, Media Harbour, Düsseldorf

future: financing biotech and life sciences March, 1 st 2016, Hyatt

2 11:30 Registration opens 12:00 Architecture Walk: Hidden Rooms in the Media Harbour 13:00 Fingerfood 13:30 Welcome Note Dr. Beate Wieland, Director General Research and Technology, Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia, Düsseldorf 13:40 Introductory Dr. Bernward Garthoff, Chair of Cluster Biotechnology North Rhine-Westphalia Düsseldorf Session 1: EIT investments into the European future in Health Care 13:50 Martin Kern, Interim Director/Chief Operating Officer, EIT European Institute of Innovation & Technology, Budapest Welcome Address Sylvie Bove, CEO, EIT Health Headquarter The Private-Equity internet based investment platform connected to BA/investors network 14:10 Demonstration and Kick-off including short video clips: Kristina Bruellhoff, CEO, PS Biotech GmbH Andreas Schmidt, CEO, AYOXXA Biosystems GmbH, Cologne Dr. Georg Schaumann, Founder, SenseUP GmbH, Jülich Comments of customers having had a preview Roland Oetker, CEO, ROI Verwaltungsgesellschaft mbh, Düsseldorf and BIO.NRW Business Angel network and those such as NRW.Bank, Deutsche Börse und EIT Health partners

Bernward Garthoff, Chair of Cluster Biotechnology North Rhine-Westphalia Düsseldorf Session 1: EIT investments into the European future in Health Care 13:50 Martin Kern, Interim Director/Chief

3 14:45 Coffee Break Session 2: Governmental investment programs 15:15 Investments programs: what has worked, what will work projects started Dr. Peter Güllmann, Head of Corporate Finance & Infrastructure Finance, NRW.Bank, Düsseldorf 15:35 European Angels Fund success and other ways to finance technology transfer Serge Rollinger, Investment Manager, European Investment Fund, Luxembourg 15:55 Supporting biotech startups activities of the Federal Government Dr. Johannes Velling, Head of Section, Federal Ministry of Economics and Energy, Berlin 16:15 Governmental investment programs: small footprints and legal pitfalls, in particular hidden legal risk of repayment penalties due to tender obligations Dr. Benjamin Monheim and Dr. Karsten Lisch, Partner, Life Sciences and Healthcare, Osborne Clarke, Cologne 16:35 Coffee Break Session 3: Alternative funding ideas and investments 17:00 High Tech Gründerfonds: Life Sciences a somewhat more difficult area to develop Dr. Philipp Rittershaus, Investment Manager Life Sciences, High-Tech Gründerfonds Management GmbH, Bonn 17:20 Coaching in the US made in Germany Katrin Lange, Chamber of Commerce and Industry, Düsseldorf 17:40 Attracting public funds how much of an alternative? Dr. Anke Empting, Senior Manager, KPMG Rechtsanwaltsgesellschaft mbh, Düsseldorf

Bank, Düsseldorf 15:35 European Angels Fund success and other ways to finance technology transfer Serge Rollinger, Investment Manager, European Investment Fund, Luxembourg 15:55 Supporting biotech

4 17:50 Is crowdfunding a real alternative for life science investments? Gonçalo de Vasconcelos, CEO, SyndicateRoom, Cambridge, UK General Discussion Comments by: Dr. Patrick Pfeffer, aescuvest GmbH, Frankfurt am Main Prof. Dr. Horst Domdey, Bio M Biotech Cluster Development GmbH, Munich 18:10 Governmental investment programs and alternatives: Lip service or change management? Moderation: Dr. Bernward Garthoff, Chair of Cluster Biotechnology North Rhine-Westphalia Düsseldorf Discussants among others: Wolfgang Kintzel, Head of Life Sciences & Cleantech, NRW.Bank, Düsseldorf Univ.-Prof. em. Dr. Detlev Riesner, Heinrich-Heine-University, Düsseldorf Roland Oetker, CEO, ROI Verwaltungsgesellschaft mbh, Düsseldorf / BIO.NRW Business Angel network Andreas Schmidt, CEO, AYOXXA Biosystems GmbH, Cologne 18:45 Networking Dinner Sponsored by Dentons, Frankfurt

Horst Domdey, Bio M Biotech Cluster Development GmbH, Munich 18:10 Governmental investment programs and alternatives: Lip service or change management? Moderation: Dr.

5 REGISTRATION 5 th BIO.NRW Business Angel Congress Next level investing into the high-tech future: financing biotech and life sciences March 1 st 2016, Hyatt Regency, Media Harbour, Düsseldorf Registrations must be received in writing by letter, fax ( ), or (krumnow@bioclustermanagement.de) Name, First Name Company or Organisation Phone Invoicing Adress Company or Organisation Name, First Name Street Zip Code City Country Member of the I will attend I will attend the Förderverein the Architecture Walk Networking Dinner Biotechnologie NRW e.v. Registration Fee: 100, Euro plus VAT Members of the Förderverein Biotechnologie NRW e.v. get a 10% discount

Registrations must be received in writing by letter, fax (+49 211 385469 9220), or e-mail (krumnow@bioclustermanagement.

6 Please register under: Maps & Directions For detailed information please visit the Hyatt Homepage under: An Event of Sponsors Media Sponsor

Start-Ups, Digital Entrepreneurs and Investors

Bavarian Ministry of Economic Affairs and Media, Energy and Technology Bavaria an Ideal Location for Start-Ups, Digital Entrepreneurs and Investors www.stmwi.bayern.de Bavaria an ideal location for Start-Ups,